Pediatrics professor Bonnie Halpern-Felsher shares her research on teens' perceptions of e-cigarettes and their health risks.
Patients who receive prescriptions for both opioids and benzodiazepines are more likely to use opioids long term, Stanford researchers have found.
Health care policy issues are at the top of U.S. lawmakers' agendas, Congresswoman Zoe Lofgren (D-Calif.) says during a Stanford Health Policy Forum.
A new Stanford study shows that people incorrectly think cigarettes with ecofriendly packaging are healthier and less harmful to the environment.
Researcher joins Stanford Medicine as a postdoctoral scholar in the Systems Neuroscience and Pain Lab to help others overcome addiction and incarceration.
New Stanford research suggests that young people begin using nicotine products like e-cigarettes by trying fruit, mint or candy flavors.
Stanford researchers disprove the idea that legalizing medical marijuana will lead to fewer deaths from opioid overdoses.
Stanford pain researchers say we can curb the prescription opioid crisis, while treating pain, by using a variety of tactics.
A new study has found that opioid-related deaths are highest on the East Coast and opioids are affecting an increasing number of African-Americans.
Experts studying nicotine and e-cigarette norms say that Juul has instigated a "nicotine arms race," causing a shift across the e-cigarette industry.
Alvin Roth, a Nobel laureate and Stanford faculty member, explains how the economic concept of repugnant markets applies to heroin in the United States.
Small trial conducted by Stanford researchers links activity in the brain's reward processing system with drug relapse in patient cohort.
Young people prescribed opioids by dental providers were at increased risk of developing opioid addiction in the following year, a Stanford study found.
An anti-smoking ad campaign featuring a woman with depression helps smokers with mental health conditions attempt to quit.
During a talk at Stanford, journalist and author Barry Meier discussed his nearly two-decade long investigation into OxyContin and Purdue Pharma.
A recent NOVA episode focused on our country's addiction problem and highlighted the work of numerous researchers.
